• Áreas Terapéuticas
  • Productos
    • Indicaciones
  • Profesionales Sanitarios
nmCRPC and Survival with Darolutamide
Ir al contenido
Oncología

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Fizazi K, et al. N Engl J Med. 2020;383:1040-1049.

Contenido relacionado

OS and AEs with darolutamide vs apalutamide vs enzalutamide
CPRCnm
Treating the patient and not just the cancer
Cáncer de próstata
Comparison of darolutamide vs apalutamide and enzalutamide
CPRCnm